Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

RemSleep Holdings (RMSL) EBITDA (2022 - 2025)

RemSleep Holdings' EBITDA history spans 7 years, with the latest figure at -$2.3 million for Q3 2025.

  • For Q3 2025, EBITDA fell 1076.25% year-over-year to -$2.3 million; the TTM value through Sep 2025 reached -$2.7 million, down 62.9%, while the annual FY2024 figure was -$793548.0, 55.21% up from the prior year.
  • EBITDA for Q3 2025 was -$2.3 million at RemSleep Holdings, down from -$132552.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$124215.0 in Q1 2024 and bottomed at -$2.3 million in Q3 2025.
  • The 4-year median for EBITDA is -$221391.0 (2023), against an average of -$470859.8.
  • The largest annual shift saw EBITDA soared 83.14% in 2024 before it crashed 1076.25% in 2025.
  • A 4-year view of EBITDA shows it stood at -$1.1 million in 2022, then increased by 7.59% to -$1.1 million in 2023, then skyrocketed by 83.14% to -$178353.0 in 2024, then tumbled by 1180.2% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMSL's EBITDA are -$2.3 million (Q3 2025), -$132552.0 (Q2 2025), and -$131315.0 (Q1 2025).